AIHTA - Publications - Search - Fedratinib (Inrebic®) for the treatment of primary and secondary myelofibrosis. Update April 2021

Grössmann, N. (2021): Fedratinib (Inrebic®) for the treatment of primary and secondary myelofibrosis. Update April 2021. Oncology Fact Sheet Nr. 33.

[thumbnail of Oncology Fact Sheet Nr.33_Update.pdf]
Preview
 PDF - Sie müssen einen PDF-Viewer auf Ihrem PC installiert haben wie z. B. GSview, Xpdf oder Adobe Acrobat Reader
624kB

Item Type:Oncology Fact Sheet
Subjects:QV Pharmacology, toxicology, pharmacy > QV 60-370 Pharmacology
QZ Pathology > QZ 200-380 Neoplasms.Cysts
WB Practice of medicine > WB 300-962 Therapeutics
WH Hemic and lymphatic systems
Language:English
Series Name:Oncology Fact Sheet Nr. 33
Deposited on:04 Jan 2021 14:11
Last Modified:28 Apr 2021 11:00

Repository Staff Only: item control page